Cargando…
The Interplay between Immune System and Microbiota in Diabetes
Diabetes is not a single and homogeneous disease, but a cluster of metabolic diseases characterized by the common feature of hyperglycemia. The pathogenesis of type 1 diabetes (T1D) and type 2 diabetes (T2D) (and all other intermediate forms of diabetes) involves the immune system, in terms of infla...
Autores principales: | Moffa, Simona, Mezza, Teresa, Cefalo, Chiara M. A., Cinti, Francesca, Impronta, Flavia, Sorice, Gian Pio, Santoro, Antonio, Di Giuseppe, Gianfranco, Pontecorvi, Alfredo, Giaccari, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012204/ https://www.ncbi.nlm.nih.gov/pubmed/32082078 http://dx.doi.org/10.1155/2019/9367404 |
Ejemplares similares
-
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
por: Cefalo, Chiara Maria Assunta, et al.
Publicado: (2019) -
Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date
por: Cinti, Francesca, et al.
Publicado: (2017) -
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study
por: Moffa, Simona, et al.
Publicado: (2023) -
Effect of Vitamin D Supplementation on Obesity‐Induced Insulin Resistance: A Double‐Blind, Randomized, Placebo‐Controlled Trial
por: Cefalo, Chiara M.A., et al.
Publicado: (2018) -
Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features
por: Capece, Umberto, et al.
Publicado: (2022)